The global market for Dual-Energy X-ray Absorptiometry (DEXA) was estimated at US$637.1 Million in 2024 and is projected to reach US$912.2 Million by 2030, growing at a CAGR of 6.2% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Dual-Energy X-ray Absorptiometry (DEXA) market.
Segments: Technology (Axial DEXA Bone Densitometer, Peripheral DEXA Bone Densitometer); Type (Standalone, Portable); Application (Osteoporosis, Body Composition Analysis, Fracture Management, Bone Densitometry, Others); End-Use (Hospitals & Clinics, Diagnostic Centers, Specialty Centers, Others)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
Global 'Dual-energy X-ray Absorptiometry (DEXA)' Market - Key Trends & Drivers Summarized
Why Is Dual-Energy X-ray Absorptiometry (DEXA) Becoming a Standard in Bone and Body Composition Analysis?
The increasing prevalence of osteoporosis, obesity, and metabolic disorders has fueled the demand for accurate and non-invasive diagnostic tools, with DEXA (Dual-energy X-ray Absorptiometry) emerging as the gold standard for bone density and body composition analysis. Unlike traditional X-ray imaging, DEXA scans use low-dose radiation and dual-energy X-ray beams to differentiate between bone, fat, and lean muscle mass, providing precise measurements crucial for diagnosing osteoporosis, assessing fracture risks, and monitoring obesity-related conditions. With an aging global population and rising awareness of bone health, healthcare providers are increasingly relying on DEXA technology for early detection and preventative care.What Innovations Are Enhancing DEXA Technology?
Recent advancements in 3D imaging reconstruction, AI-driven diagnostics, and automated fracture detection have significantly improved the accuracy and efficiency of DEXA scans. The integration of high-resolution detectors has allowed for better visualization of bone microarchitecture, improving osteoporosis risk assessment. Additionally, portable and compact DEXA devices are being introduced, making bone density analysis more accessible in outpatient clinics and point-of-care settings. The use of AI-assisted analytics in DEXA scans has also streamlined diagnostic workflows, reducing human error and enabling faster clinical decision-making.How Are Regulatory Policies and Healthcare Trends Driving Market Expansion?
Governments and health organizations worldwide are implementing osteoporosis screening programs and reimbursement policies to promote early detection of bone-related disorders. The rising adoption of preventive healthcare initiatives has further increased demand for DEXA-based screenings in women’s health, sports medicine, and geriatrics. Additionally, the fitness and wellness industry is leveraging DEXA scans for body composition analysis, allowing athletes and fitness enthusiasts to track changes in muscle mass and fat distribution.What Factors Are Propelling Market Growth?
The growth in the Dual-energy X-ray Absorptiometry (DEXA) market is driven by increasing osteoporosis cases, advancements in AI-based imaging, and expanding applications in fitness and metabolic health analysis. The rising geriatric population, improved accessibility of portable DEXA devices, and government-backed screening programs are further fueling demand. Additionally, as healthcare providers seek accurate, fast, and non-invasive diagnostic tools, the adoption of DEXA technology is expected to rise significantly across hospitals, diagnostic centers, and sports clinics.Report Scope
The report analyzes the Dual-Energy X-ray Absorptiometry (DEXA) market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.Segments: Technology (Axial DEXA Bone Densitometer, Peripheral DEXA Bone Densitometer); Type (Standalone, Portable); Application (Osteoporosis, Body Composition Analysis, Fracture Management, Bone Densitometry, Others); End-Use (Hospitals & Clinics, Diagnostic Centers, Specialty Centers, Others)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Axial DEXA Bone Densitometer segment, which is expected to reach US$539.5 Million by 2030 with a CAGR of a 5.0%. The Peripheral DEXA Bone Densitometer segment is also set to grow at 8.1% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $173.6 Million in 2024, and China, forecasted to grow at an impressive 9.5% CAGR to reach $184.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Dual-Energy X-ray Absorptiometry (DEXA) Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Dual-Energy X-ray Absorptiometry (DEXA) Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Dual-Energy X-ray Absorptiometry (DEXA) Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Aurora Spine, BeamMed Ltd., Diagnostic Medical Systems (DMS), DMS Imaging, DMS Imaging STRATOS DR and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 32 Featured):
- Aurora Spine
- BeamMed Ltd.
- Diagnostic Medical Systems (DMS)
- DMS Imaging
- DMS Imaging STRATOS DR
- Fonar Corporation
- Fujifilm Holdings Corporation
- Fujifilm Medical Systems
- Furuno Electric Co., Ltd.
- GE Healthcare
- GE HealthCare Lunar
- Henry Schein, Inc.
- Hologic Discovery Series
- Hologic, Inc.
- Hologic`s Horizon DXA System
- L`ACN - l`Accessorio Nucleare
- LaiFU Medical Equipment
- Medical Econet GmbH
- Medilink International
- Medonica Co., Ltd.
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
What’s Included in This Edition:
- Tariff-adjusted market forecasts by region and segment
- Analysis of cost and supply chain implications by sourcing and trade exposure
- Strategic insights into geographic shifts
Buyers receive a free July 2025 update with:
- Finalized tariff impacts and new trade agreement effects
- Updated projections reflecting global sourcing and cost shifts
- Expanded country-specific coverage across the industry
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aurora Spine
- BeamMed Ltd.
- Diagnostic Medical Systems (DMS)
- DMS Imaging
- DMS Imaging STRATOS DR
- Fonar Corporation
- Fujifilm Holdings Corporation
- Fujifilm Medical Systems
- Furuno Electric Co., Ltd.
- GE Healthcare
- GE HealthCare Lunar
- Henry Schein, Inc.
- Hologic Discovery Series
- Hologic, Inc.
- Hologic`s Horizon DXA System
- L`ACN - l`Accessorio Nucleare
- LaiFU Medical Equipment
- Medical Econet GmbH
- Medilink International
- Medonica Co., Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 77 |
| Published | April 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 637.1 Million |
| Forecasted Market Value ( USD | $ 912.2 Million |
| Compound Annual Growth Rate | 6.2% |
| Regions Covered | Global |
